ArticleDigestive diseases and sciences2013

Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis.

Sang Hyoung Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.